Eli Lilly's Taltz touts long-term clear skin data after unimpressive first-quarter sales

Eli Lilly's Taltz touts long-term clear skin data after unimpressive first-quarter sales

Source: 
Fierce Pharma
snippet: 

After five years of treatment, Taltz significantly cleared skin in 94.3% of moderate-to-severe plaque psoriasis patients and maintained totally clear skin in 46.6% of patients, according to data presented Tuesday at the World Congress of Dermatology meeting in Milan, Italy. Lilly said the five-year data did not turn up any new side effects in the 110 patients who participated in the study.